Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Sales Representative, Applied Biosystems